ArticleOncotarget2017

Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection.

Sun Zongwen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.